For citations:
Teplyakov A.T., Kuznetsova A.V., Protopopova N.V., Andriyanova A.V., Suslova T.E., Nasanova O.N., Kalyuzhin V.V. LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE? Bulletin of Siberian Medicine. 2015;14(2):47-54. (In Russ.) https://doi.org/10.20538/1682-0363-2015-2-47-54
Email this article 